NCT06925685View on ClinicalTrials.gov

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Enrolling by invitationOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2039

Study Completion Date

January 31, 2039

Conditions
Hematologic MalignanciesSolid Tumors
Trial Locations (1)

14203

Circuit Clinical, Buffalo

Sponsors
All Listed Sponsors
lead

Allogene Therapeutics

INDUSTRY

NCT06925685 - Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product | Biotech Hunter | Biotech Hunter